On 15 August 2022, the Medicines and Healthcare products Regulatory Agency (MHRA) granted regulatory approval for the Moderna bivalent COVID-19 vaccine. After reviewing data on booster responses from different combinations of COVID-19 vaccines, the UK, following JCVI advice, will deploy vaccines which are targeted at both Omicron and the original strain of COVID-19.
There are no results that match your search criteria